Vmbook Online ordering

Icons

**Company Information**

**Name:** SIM-Surg, Inc.

**Symbol:** SIM-S

**Exchange:** Nasdaq Capital Market

**Sector:** Healthcare Equipment and Services

**Industry:** Surgical Equipment and Supplies

**Key Financial Metrics**

**Revenue:**

* 2022: $26.4 million

* 2021: $20.1 million

* Growth: 31.3%

**Net Income:**

* 2022: $1.9 million

* 2021: $0.9 million

* Growth: 111.1%

**Earnings Per Share (EPS):**

* 2022: $0.14

* 2021: $0.06

* Growth: 133.3%

**Growth Prospects**

* Expanding product portfolio with innovative surgical technologies

* Growing demand for minimally invasive surgical procedures

* Strategic partnerships with healthcare providers and distributors

**Key Business Highlights**

* **SIM-Surg System:** A surgical navigation and visualization platform used in spine, orthopedic, and neurosurgery procedures.

* **SIM-Surg Academy:** A training and education platform for surgeons using the SIM-Surg System.

* **SIM-Surg Cloud:** A cloud-based platform for data storage, analysis, and collaboration.

**Risks and Challenges**

* Competition from established medical device companies

* Regulatory approvals and compliance requirements

* Dependence on third-party distributors

**Analyst Coverage**

* **Consensus Rating:** Buy

* **Target Price:** $10.00 (as of March 8, 2023)

**Recent News and Events**

* **Q4 2022 Earnings Release:** Announced strong revenue and earnings growth, exceeding analyst expectations.

* **Partnership with Stryker:** Entered into a distribution agreement with Stryker to expand the reach of the SIM-Surg System.

* **FDA Clearance for New Product:** Received FDA clearance for a new surgical navigation system for use in spinal procedures.